FDA approves Strativa’s Nascobal spray
WOODCLIFF LAKE, N.J. — Strativa Pharmaceutical, a division of Par Pharmaceutical Cos., announced that the Food and Drug Administration approved Nascobal, a prescription B-12 supplement administered once a week as one spray.
"Unlike the current device, our new Nascobal single-use device does not require priming, which eliminates product loss. In addition, it permits patients to conveniently receive their dose with one spray per disposable device," said Rick Painter, SVP, brand sales and marketing. "Strativa remains committed to improving the product experience of the patients who rely upon us."
The device delivers 500 mcg of cyanocobalamin, USP with each spray. A carton of four single-use devices gives the patient a one month supply of Nascobal. The drug will be available in pharmacies in September.
Mylan launches generic Actonel tablets
PITTSBURGH — Mylan on Wednesday announced the launch of risedronate sodium tablets USP, 150 mg. The drug is the generic version of Actonel tablets from Warner Chilcott and is used for the treatment of osteoporosis in post-menopausal women, according to the company.
Risedronate sodium tablets USP had sales in the United States of $171.6 million for the 12 months ending March 31, 2014, according to IMS Health.
SAP unveils tech, trends in food retail
NEW YORK — It is no secret that the retail landscape is evolving, as many factors — such as mobile technology, healthy eating trends and cost cutting — increasingly impact how people shop.
Using the SAP Social Media Analytics application by NetBase, SAP analyzed social media conversations to gain insight into people’s perceptions about grocery shopping.
Insights included four personas that make up the food retail audience, how shoppers are using mobile technology, how trends are affecting how shoppers feel about food and how loyalty programs and bargains win with shoppers.